Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Current Assets (2016 - 2025)

Historic Current Assets for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to $8.1 million.

  • Milestone Scientific's Current Assets fell 2419.51% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year decrease of 2419.51%. This contributed to the annual value of $9.3 million for FY2024, which is 1396.93% down from last year.
  • As of Q3 2025, Milestone Scientific's Current Assets stood at $8.1 million, which was down 2419.51% from $7.6 million recorded in Q2 2025.
  • In the past 5 years, Milestone Scientific's Current Assets ranged from a high of $21.7 million in Q1 2021 and a low of $7.6 million during Q2 2025
  • Over the past 5 years, Milestone Scientific's median Current Assets value was $11.5 million (recorded in 2024), while the average stood at $13.2 million.
  • As far as peak fluctuations go, Milestone Scientific's Current Assets skyrocketed by 31168.2% in 2021, and later crashed by 3646.29% in 2023.
  • Quarter analysis of 5 years shows Milestone Scientific's Current Assets stood at $18.9 million in 2021, then crashed by 31.5% to $13.0 million in 2022, then dropped by 16.78% to $10.8 million in 2023, then dropped by 13.97% to $9.3 million in 2024, then decreased by 12.67% to $8.1 million in 2025.
  • Its last three reported values are $8.1 million in Q3 2025, $7.6 million for Q2 2025, and $8.6 million during Q1 2025.